Cargando…
Long Noncoding RNA CCAT2 as a Potential Novel Biomarker to Predict the Clinical Outcome of Cancer Patients: A Meta-Analysis
Background: Colon Cancer-Associated Transcript 2 (CCAT2) has been demonstrated associated with clinical outcomes in various tumors. However, the results from each study were unfortunately insufficient and not completely consistent. Therefore, we conduct a systematic meta-analysis to evaluate the val...
Autores principales: | Tan, Juan, Hou, Yi-Chao, Fu, Lin-Na, Wang, Yun-Qian, Liu, Qian-Qian, Xiong, Hua, Chen, Ying-Xuan, Fang, Jing-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479257/ https://www.ncbi.nlm.nih.gov/pubmed/28638466 http://dx.doi.org/10.7150/jca.18626 |
Ejemplares similares
-
Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma
por: Fang, Hua, et al.
Publicado: (2018) -
Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
por: Cai, Yi, et al.
Publicado: (2015) -
Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer
por: Hua, Fu, et al.
Publicado: (2018) -
Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Dailian, et al.
Publicado: (2017) -
Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)